Published in J Mol Biol on May 20, 1986
Effects of palindromes on in vivo DNA replication and mutagenesis in bacteriophage phi X174 RF DNA. Nucleic Acids Res (1988) 0.77
Microarray-based STR genotyping using RecA-mediated ligation. Nucleic Acids Res (2010) 0.75
DNA structure and gene regulation. Prog Nucleic Acid Res Mol Biol (1980) 2.88
Evolutionary selection for perfect hairpin structures in viral DNAs. Nature (1982) 1.50
Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol (1995) 1.47
Intercistronic regions in phi X174 DNA. II. Biochemical and biological analysis of mutants with altered intercistronic regions between genes J and F. J Mol Biol (1980) 1.39
Avian retrovirus pp32 DNA binding protein. Preferential binding to the promoter region of long terminal repeat DNA. Biochemistry (1984) 1.39
Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy (1996) 1.32
Role for the J-F intercistronic region of bacteriophages phi X174 and G4 in stability of mRNA. J Virol (1983) 1.30
Fetal cells in maternal blood: recovery by charge flow separation. Hum Genet (1996) 1.11
Intercistronic regions in phi X174 DNA. I. Construction of mutants with altered intercistronic regions between genes J and F. J Mol Biol (1980) 1.10
Eclipse kinetics as a probe of quaternary structure in bacteriophage phi X174. J Mol Biol (1985) 1.02
Effects of palindrome size and sequence on genetic stability in the bacteriophage phi X174 genome. J Mol Biol (1987) 0.99
Enzymatic construction and selection of bacteriophage G4 mutants with modifications of a DNA secondary structure in the J-F intercistronic region. J Virol (1983) 0.96
Novel surface and multicolor charge coupled device-based fluorescent imaging system for DNA microarrays. J Biomed Opt (2001) 0.95
Adaptation of capillary isoelectric focusing to microchannels on a glass chip. Anal Chem (1999) 0.93
Are anaphylactic reactions to snake bites immunoglobulin E-mediated? Clin Exp Allergy (2000) 0.92
Construction of bacteriophage luminal diameterX174 mutants with maximum genome sizes. J Virol (1984) 0.92
Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology. Allergy (1987) 0.91
Bee sting allergy in beekeepers. Clin Exp Allergy (1998) 0.89
Long-term protection after stopping venom immunotherapy: results of re-stings in 200 patients. J Allergy Clin Immunol (1998) 0.87
The effect of transfer ribonucleic acid on virally modified valyl transfer ribonucleic acid synthetase of Escherichia coli. J Biol Chem (1974) 0.86
The effect of supercoil and temperature on the recognition of palindromic and non-palindromic regions in phi X174 replicative form DNA by S1 and Bal31. J Biol Chem (1987) 0.85
The Drosophila suppressor of sable protein binds to RNA and associates with a subset of polytene chromosome bands. Mol Cell Biol (1997) 0.85
Mutations in the J-F intercistronic region of bacteriophages phi X174 and G4 affect the regulation of gene expression. J Virol (1983) 0.85
Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings. Allergy (2010) 0.85
Theoretical evidence for the significance of certain types of DNA secondary structure in the genomes of phi X174, G4, fd, SV40 and the plasmid pBR322. Prog Clin Biol Res (1981) 0.84
Combined active and passive immunotherapy in honeybee-sting allergy. J Allergy Clin Immunol (1986) 0.83
Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays. Toxicol In Vitro (2003) 0.81
Withdrawal of the Medihaler-epi/Adrenaline Medihaler: comments of the Subcommittee on Insect Venom Allergy of the EAACI. Allergy (1998) 0.81
Purification and properties of a T4 bacteriophage factor that modifies valyl-tRNA synthetase of Escherichia coli. J Biol Chem (1977) 0.81
Temporal appearance of bacteriophage T4-modified valyl tRNA synthetase in Escherichia coli. J Virol (1975) 0.80
Elevated baseline serum tryptase, mastocytosis and anaphylaxis. Clin Exp Allergy (2009) 0.79
Studies of coexisting honeybee and vespid-venom sensitivity. J Allergy Clin Immunol (1984) 0.79
Anaphylaxis after Hymenoptera stings in three patients with urticaria pigmentosa. J Allergy Clin Immunol (1983) 0.79
Effect of in vitro transcription on cruciform stability. Nucleic Acids Res (1990) 0.79
Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH-1 or TH-2-like cytokine patterns. Clin Exp Allergy (1995) 0.78
Analysis of the structure of T4 bacteriophage-modified valyl-tRNA synthetase by limited proteolysis and isoelectric focusing. J Biol Chem (1977) 0.78
Venom immunotherapy: aqueous vs aluminium hydroxide adsorbed extracts. Allergy (2004) 0.78
Hymenoptera venom hypersensitivity: an update. Clin Exp Allergy (1998) 0.76
Colorectal intussusception: an unusual gastrointestinal complication of hereditary angioedema. Int Arch Allergy Immunol (1996) 0.76
Uterine contractions are known side effects of venom immunotherapy. J Investig Allergol Clin Immunol (2011) 0.75
Duration of venom immunotherapy. J Allergy Clin Immunol (1997) 0.75
Ultra rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate. Clin Exp Allergy (1995) 0.75
Use of dialyzed venoms in the radioallergosorbent test. Int Arch Allergy Appl Immunol (1984) 0.75
Extraction and differentiation of the Su autoantigen from calf thymus nuclei. J Immunol Methods (1991) 0.75
Peptide immunotherapy. Allergy (1999) 0.75
The biological significance of G-T/G-U mispairing in nucleic acid secondary structure. J Theor Biol (1985) 0.75